The demand for advanced Neurodegenerative Disease Devices is being significantly driven by the growing burden of progressive ...

The aim of this review is to present the current state of knowledge on deep brain stimulation (DBS) in pediatric patients with acquired dystonia. We summarize the short- and long-term effects of DBS ...

Medtronic has partnered with Precision Neuroscience to pair a brain computer interface with its neurosurgical platform. The agreement, which the companies disclosed Monday, supports co-development of ...

Medtronic Plc is partnering with brain implant company Precision Neuroscience Corp. in a deal that will give the medical device maker access to neural data it can use to develop new products. As part ...

Medtronic reported that its new thrombectomy system, aimed at removing blood clots from the arms and legs, has begun its commercial rollout with its first procedures. At the same time, the medtech ...

The Percept RC deep brain stimulation system [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + announced that the FDA approved expanded labeling for its deep brain stimulation (DBS) offering. The ...

In 2003, Medtronic first received a humanitarian green light from the FDA to offer its deep brain stimulation implants to treat the symptoms of dystonia—the painful movement disorder that can cause ...

DUBLIN, Oct. 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that BrainSense™ Adaptive Deep Brain Stimulation (aDBS) – the world's first ...

DUBLIN, Oct. 9, 2025 /PRNewswire/ -- Medtronic plc (MDT) (NYSE: MDT), a global leader in healthcare technology, today announced that BrainSense™ Adaptive Deep Brain Stimulation (aDBS) – the world's ...